Privia Health delivered a strong fourth quarter, with all 2025 operating and financial metrics meeting or exceeding the high end of guidance. The company achieved significant growth in net income and Adjusted EBITDA, ending the year with a robust cash position of $479.7 million and no debt.

Privia Health's Q3 2025 performance was marked by significant growth across revenue, net income, and key operating metrics. The company raised FY 2025 guidance and announced a strategic acquisition that will expand its value-based care reach.

Privia Health delivered a very strong performance in the second quarter of 2025, exceeding expectations with substantial growth in revenue, practice collections, and profitability. The company's strategic initiatives, including new provider additions and expansion into new markets, contributed to robust financial outcomes and led to raised full-year guidance.

Privia Health reported strong first quarter 2025 financial results with significant growth in total revenue, net income, and Adjusted EBITDA compared to the same period last year. The company also announced its entrance into the state of Arizona and raised its full-year 2025 outlook for most financial metrics.

Privia Health reported strong Q4 2024 results, exceeding guidance ranges with a 4.6% increase in total revenue to $460.9 million and a 55.0% increase in net income to $4.4 million. The company's implemented providers increased by 11.2% year-over-year, and adjusted EBITDA grew by 44.0% to $24.9 million.

Privia Health reported a 4.9% increase in total revenue, reaching $437.9 million. The company's adjusted EBITDA grew by 25.8% to $23.6 million, and cash and cash equivalents increased by 27.7% to $422.0 million. They also delivered MSSP 2023 Shared Saving of $176.6 Million, +34.1% versus 2023

Privia Health reported a 2.2% increase in total revenue, reaching $422.3 million, and an 8.9% increase in gross profit, amounting to $98.3 million. The company also highlighted a 16.4% increase in implemented providers and a 10.7% increase in value-based care attributed lives.

Privia Health reported a 7.5% increase in total revenue, reaching $415.2 million, and a gross profit increase of 12.5% to $93.4 million. The company reiterated its full-year 2024 guidance, focusing on growth in implemented providers and value-based care attributed lives.

Privia Health reported a 21.0% increase in total revenue for Q4 2023, reaching $440.8 million, and a net income of $2.8 million. The company achieved growth in practice collections, care margin, and platform contribution. They are proactively addressing challenges in the Medicare Advantage market and focusing on strategic initiatives for 2024.

Privia Health reported a strong third quarter with a 21.7% increase in revenue compared to the prior year, reaching $417.3 million. The company also saw improvements in profitability, with operating income of $5.5 million compared to an operating loss in the previous year. Net income increased to $5.6 million, and non-GAAP adjusted net income rose to $21.1 million.

Privia Health reported a strong second quarter in 2023, with a 23.2% increase in revenue to $413.4 million. The company achieved net income of $7.3 million, a significant improvement from the net loss of $(10.5) million in the same quarter last year. Key metrics, including practice collections, care margin, and attributed lives, also showed substantial growth.

Privia Health reported a strong first quarter in 2023, with revenue increasing by 23.1% compared to the previous year. The company also saw improvements in gross profit and operating income, and reiterated its full-year 2023 guidance.

Privia Health reported a strong fourth quarter in 2022, with a 32.4% increase in revenue compared to the previous year. The company's operating income turned positive, and net income significantly improved. Key operating metrics such as practice collections, care margin, and platform contribution also showed substantial growth.

Privia Health reported a strong third quarter with significant growth in implemented providers, practice collections, and care margin. The company also announced new market entries with health systems in North Carolina and Ohio, expanding its reach and opportunities for future growth.

Privia Health reported strong growth in Q2 2022, with a significant increase in practice collections, implemented providers, and value-based care attributed lives. The company's revenue and adjusted EBITDA also saw substantial growth compared to the prior year. Privia Health repaid all outstanding debt in the quarter.

Privia Health reported strong first quarter results with a 46.9% increase in total revenue compared to the prior year. The company saw significant growth in practice collections, care margin, and adjusted EBITDA. They are focused on expanding provider partnerships, increasing attributed lives, and entering new markets.

Privia Health's Q4 2021 financial performance showed strong growth, with practice collections, care margin, and adjusted EBITDA exceeding the high end of the company's full-year financial guidance. The company also saw growth in implemented providers and attributed lives, and is expanding into new markets.

Privia Health reported strong growth in Q3 2021, with practice collections increasing by 18.1%, care margin growing by 31.5%, and adjusted EBITDA up by 51.9% compared to the third quarter last year. The company also saw a 15.2% growth of implemented providers and a 17.6% increase in attributed lives.

Privia Health reported a revenue of $225.8 million for the second quarter of 2021, a 23.2% increase compared to the previous year. The company experienced an operating loss of $193.2 million and a net loss of $172.5 million, primarily due to non-cash stock compensation expenses related to its IPO. Excluding these expenses, non-GAAP adjusted net income was $10.4 million, or $0.09 per diluted share.

Privia Health Group, Inc. reported a slight increase in total revenue for the first quarter of 2021, with a more significant increase in operating income. Net income remained relatively stable compared to the prior year. The company is focused on expanding attributed lives, adding providers, entering new markets, and driving profit margin expansion.